呼吸肌锻炼对机器人辅助前列腺癌根治术老年患者术后肺不张的影响

注册号:

Registration number:

ChiCTR2000034983 

最近更新日期:

Date of Last Refreshed on:

2020-07-27 03:12:32 

注册时间:

Date of Registration:

2020-07-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

呼吸肌锻炼对机器人辅助前列腺癌根治术老年患者术后肺不张的影响

Public title:

Effect of respiratory muscle exercise on postoperative atelectasis in eldrerly patients undergoing robot-assisted radical prostatectomy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

保护性机械通气策略对机器人辅助腹腔镜手术患者术后呼吸系统并发症的影响

Scientific title:

Influence of protective mechanical ventilation strategy on postoperative respiratory complications of robot-assisted laparoscopic surgery patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

苏学森 

研究负责人:

武晓丽 

Applicant:

Xuesen Su 

Study leader:

Xiaoli Wu 

申请注册联系人电话:

Applicant telephone:

+86 18334720621

研究负责人电话:

Study leader's
telephone:

+86 15135103505

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

674473219@qq.com

研究负责人电子邮件:

Study leader's E-mail:

44184712@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山西省太原市迎泽区解放南路85号

研究负责人通讯地址:

山西省太原市迎泽区解放南路85号

Applicant address:

85 Jiefang Road South, Yingze District, Taiyuan, Shanxi, China

Study leader's address:

85 Jiefang Road South, Yingze District, Taiyuan, Shanxi, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山西医科大学第一医院

Applicant's institution:

Shanxi Medical University First Hospital

研究负责人所在单位:

山西医科大学第一医院

Affiliation of the Leader:

Shanxi Medical University First Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2019]伦审(K015)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

山西医科大学第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shanxi Medical University First Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2019-04-09 00:00:00

伦理委员会联系人:

刘中国

Contact Name of the ethic committee:

Zhongguo Liu

伦理委员会联系地址:

山西省太原市迎泽区解放南路85号

Contact Address of the ethic committee:

85 Jiefang Road South, Yingze District, Taiyuan, Shanxi, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山西医科大学第一医院

Primary sponsor:

First Hospital of Shanxi Medical University

研究实施负责(组长)单位地址:

山西省太原市迎泽区解放南路85号

Primary sponsor's address:

85 Jiefang South Road, Yingze District,Taiyuan City,Shanxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山西省

市(区县):

Country:

China

Province:

Shanxi

City:

单位(医院):

山西医科大学第一医院

具体地址:

山西太原市迎泽区解放南路85号

Institution
hospital:

Frist Hospital of Shanxi Medical University

Address:

No.85 Jiefang South Road, Yingze District,Taiyuan City,Shanxi Province

经费或物资来源:

山西医科大学第一医院院级基金(YJ161709)

Source(s) of funding:

Hospital-level Fund of the First Hospital of Shanxi Medical University(YJ161709)

研究疾病:

术后肺部并发症  

Target disease:

Postoperative pulmonary complications

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

半随机对照 

Study design:

Quasi-randomized controlled 

研究目的:

评价术前呼吸肌功能锻炼对机器人辅助前列癌根治术老年患者术后肺不张的影响  

Objectives of Study:

To evaluate the effect of preoperative respiratory muscle function exercise on postoperative atelectasis in elderly patients with robot-assisted radical prostatectomy

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

合并严重的呼吸系统并发症,包括COPD、肺大泡、支气管扩张、哮喘、严重睡眠呼吸暂停综合征、肺间质纤维化、肺心病等;
合并严重的心血管系统并发症,包括先天性心脏病、严重心率失常、冠心病、心梗、心衰、心肌病等;
无法配合术前呼吸肌锻炼;
曾接受过胸科手术或近6个月接受过外科手术;
未进行术前胸部CT检查患者;
术后无法拔除气管导管患者。

Exclusion criteria:

1. Patients with serious respiratory complications, including COPD, pulmonary bullae, bronchiectasis, asthma, severe sleep apnea syndrome, pulmonary fibrosis, pulmonary heart disease, etc.;
2. Patients with serious cardiovascular system complications, including congenital heart disease, severe arrhythmia, coronary heart disease, myocardial infarction, heart failure, cardiomyopathy, etc.;
3. Cannot cooperate with preoperative respiratory muscle exercise;
4. Patients have undergone thoracic surgery or surgery in the past 6 months;
5. Patients without preoperative chest CT examination
6. Patients who cannot remove the tracheal tube after surgery.

研究实施时间:

Study execute time:

From 2020-08-01 00:00:00 To 2021-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-08-01 00:00:00 To 2021-01-15 00:00:00

干预措施:

Interventions:

组别:

E组

样本量:

15

Group:

Group E

Sample size:

干预措施:

术前呼吸肌锻炼+术中肺保护通气策略

干预措施代码:

Intervention:

peroperative respiratory muscle exercise + intraoperative lung protection ventilation

Intervention code:

组别:

P组

样本量:

15

Group:

Group P

Sample size:

干预措施:

术中肺保护通气策略

干预措施代码:

Intervention:

intraoperative lung protection ventilation

Intervention code:

组别:

C组

样本量:

15

Group:

Group C

Sample size:

干预措施:

干预措施代码:

Intervention:

Nothing

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山西省 

市(区县):

 

Country:

China

Province:

Shanxi

City:

单位(医院):

山西医科大学第一医院 

单位级别:

三甲医院 

Institution
hospital:

Frist Hospital of Shanxi Medical Univercity

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

氧合指数

指标类型:

次要指标

Outcome:

Oxygenation index

Type:

Secondary indicator

测量时间点:

诱导前;插管后1h;拔管前30min;拔管后30min;术后24h

测量方法:

动脉血气分析

Measure time point of outcome:

Before induction; 1h after intubation; 30 min before extubation; 30min after extubation; 24h after surgery

Measure method:

Arterial blood gas analysis

指标中文名:

肺部CT

指标类型:

主要指标

Outcome:

Pulmonary computer tomography scans

Type:

Primary indicator

测量时间点:

拔管后1h;术后24h

测量方法:

胸部CT检查

Measure time point of outcome:

1h extubation; 24h after surgery;

Measure method:

Chest CT examination

指标中文名:

呼气末CO2

指标类型:

次要指标

Outcome:

PetCO2

Type:

Secondary indicator

测量时间点:

诱导前;插管后1h;拔管前30min;拔管后30min;术后24h

测量方法:

Measure time point of outcome:

Before induction; 1h after intubation; 30 min before extubation; 30min after extubation; 24h after surgery

Measure method:

指标中文名:

肺顺应性

指标类型:

次要指标

Outcome:

Lung compliance

Type:

Secondary indicator

测量时间点:

插管后1h;拔管前30min;

测量方法:

Measure time point of outcome:

1h after intubation; 30 min before extubation

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

动脉血

组织:

Sample Name:

Arterial blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

参试者病历号的奇偶性

Randomization Procedure (please state who generates the random number sequence and by what method):

Odd-even of patients hospotal number

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Open

Blinding:

Open

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国知网;万方数据平台

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

CNKI;Wanfang Data

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表: 数据管理:ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

EDC: ResMan

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-07-27 02:46:24